iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Up 30.1% in January

Posted by Patrick Bannon on Feb 16th, 2026

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report) saw a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 8,781 shares, an increase of 30.1% from the January 15th total of 6,747 shares. Currently, 0.2% of the company’s stock are short sold. Based on an average daily trading volume, of 52,967 shares, the short-interest ratio is currently 0.2 days. Based on an average daily trading volume, of 52,967 shares, the short-interest ratio is currently 0.2 days. Currently, 0.2% of the company’s stock are short sold.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

Several hedge funds have recently made changes to their positions in IDNA. Flow Traders U.S. LLC bought a new position in shares of iShares Genomics Immunology and Healthcare ETF during the second quarter worth about $931,000. Portland Global Advisors LLC acquired a new position in shares of iShares Genomics Immunology and Healthcare ETF during the second quarter worth approximately $2,099,000. Triumph Capital Management bought a new position in iShares Genomics Immunology and Healthcare ETF in the 3rd quarter worth approximately $35,000. Finally, Ameriprise Financial Inc. grew its stake in shares of iShares Genomics Immunology and Healthcare ETF by 8.4% in the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock worth $1,688,000 after purchasing an additional 5,540 shares in the last quarter.

iShares Genomics Immunology and Healthcare ETF Price Performance

IDNA opened at $29.06 on Monday. The stock has a market capitalization of $145.30 million, a PE ratio of 14.76 and a beta of 1.07. The firm’s fifty day moving average price is $27.73 and its 200 day moving average price is $25.33. iShares Genomics Immunology and Healthcare ETF has a 12-month low of $17.26 and a 12-month high of $30.30.

About iShares Genomics Immunology and Healthcare ETF

(Get Free Report)

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.